The clock is ticking, the cards are in your hands, and you need to do everything in your power to destroy your opponents’ towers before you’re toast. If you’re itching for some exclusive drops as well ...

Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2. The new ...